Ovid Therapeutics Inc

NASDAQ:OVID 4:00:00 PM EDT

1.11

+0.04 (+3.74%)

7:56:52 PM EDT: $1.04 -0.07 (-6.31%)

Market Cap (Intraday)	78.78M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.11 Million
Adjusted EPS	-$0.22

See more estimates

10-Day MA	$1.11
50-Day MA	$1.02
200-Day MA	$2.57

See more pivots

Ovid Therapeutics Inc Stock, NASDAQ:OVID

441 9th Avenue, 14th floor, New York, New York 10001

United States of America

Phone: +1.646.661.7661

Number of Employees: 40

http://www.ovidrx.com

Description

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.